| Followers | 3164 |
| Posts | 209645 |
| Boards Moderated | 1 |
| Alias Born | 02/04/2004 |
Wednesday, May 22, 2019 10:24:45 AM
lmfao so now it's a supposed "huge conflict of interest" that VYST's CEO Steve Rotman is gonna acquire his multi-generational multi-decade beyond well established Rotmans biz for favorable VYST terms, so that VYST can finally have the resources they lacked and utilize the incredible leverage Rotmans provides to implement a commercialization era for the OTC ages!
The only naivety out there is from anyone who can't be bothered believing in CEO Steve Rotman's +5 decade long more than well established biz acumen, character and pedigree that precedes him taking the VYST CEO helm, and agreeing to have VYST acquire Rotmans so that VYST's extensive roster of astute and affluent insiders could finally have the resources and leverage necessary to bring a multitude of game changing proprietary competitive advantage products to market they can all be proud of.
And I for one can't wait to see who else CEO Rotman adds to the BOD's and how many big name deals he's preparing to announce in the soon to be post Rotmans leverage era finally upon us let alone how many products and multi-media branding endeavors get launched...because the moment VYST does officially possess the resources and leverage Rotmans provides, is the exact moment that VYST embarks on an incredible up listing journey rarely ever witnessed on the OTC each year, because the over-whelming majority of OTC plays end up getting stuck in perpetual R&D phases and severely lacking the resources and leverage to ever embark on a true commercialization era that dramatically and explosively results in big money having to apply ever increasing valuation metrics to the rapid growth trajectory any OTC PubCo eventually embarks on!
CEO Rotman is building it, and much higher breeds of big boy players/big boy firms are coming...and since VYST has never even bothered to up list onto the QB by now, they're providing every indication that they're planning on skipping the QB exchange entirely and instead applying onto the OTCQX exchange instead!
So we'll soon see who's kidding who as VYST has a massive team of inter-connected teammates working on the collective growth driving mission, all of whom logic strongly suggests will soon be joined by even more directors and partner companies, as the snowball effect of organic traction kicks in with each & every fresh tangible result and growth driving catalyst VYST begins unleashing/delivering directly ahead:)
The only naivety out there is from anyone who can't be bothered believing in CEO Steve Rotman's +5 decade long more than well established biz acumen, character and pedigree that precedes him taking the VYST CEO helm, and agreeing to have VYST acquire Rotmans so that VYST's extensive roster of astute and affluent insiders could finally have the resources and leverage necessary to bring a multitude of game changing proprietary competitive advantage products to market they can all be proud of.
And I for one can't wait to see who else CEO Rotman adds to the BOD's and how many big name deals he's preparing to announce in the soon to be post Rotmans leverage era finally upon us let alone how many products and multi-media branding endeavors get launched...because the moment VYST does officially possess the resources and leverage Rotmans provides, is the exact moment that VYST embarks on an incredible up listing journey rarely ever witnessed on the OTC each year, because the over-whelming majority of OTC plays end up getting stuck in perpetual R&D phases and severely lacking the resources and leverage to ever embark on a true commercialization era that dramatically and explosively results in big money having to apply ever increasing valuation metrics to the rapid growth trajectory any OTC PubCo eventually embarks on!
CEO Rotman is building it, and much higher breeds of big boy players/big boy firms are coming...and since VYST has never even bothered to up list onto the QB by now, they're providing every indication that they're planning on skipping the QB exchange entirely and instead applying onto the OTCQX exchange instead!
So we'll soon see who's kidding who as VYST has a massive team of inter-connected teammates working on the collective growth driving mission, all of whom logic strongly suggests will soon be joined by even more directors and partner companies, as the snowball effect of organic traction kicks in with each & every fresh tangible result and growth driving catalyst VYST begins unleashing/delivering directly ahead:)
Recent VYST News
- Vystar Plans Dividend Spin Off of RXAIR and Related Brands Following R3alm, Inc. Transaction • GlobeNewswire Inc. • 04/27/2026 12:00:00 PM
- Vystar and R3alm Launch R3alm.com Following Strategic Transaction • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. • GlobeNewswire Inc. • 04/20/2026 01:22:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 06:25:19 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:33:28 PM
- Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform • GlobeNewswire Inc. • 02/18/2026 02:30:00 PM
- Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology • GlobeNewswire Inc. • 01/29/2026 03:40:00 PM
- Vystar to Acquire Stake in GoPaid and Partner with Capital R3alm to Launch R3alm Oracle and Collectibles Platform • GlobeNewswire Inc. • 01/27/2026 03:57:10 PM
- Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles • GlobeNewswire Inc. • 01/08/2026 04:40:38 PM
- Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded. • GlobeNewswire Inc. • 12/22/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 05:59:16 PM
- Incubator Stock Review Initiates Coverage on Vystar • GlobeNewswire Inc. • 10/24/2025 02:05:00 PM
- Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale • GlobeNewswire Inc. • 10/17/2025 12:30:00 PM
- Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box • GlobeNewswire Inc. • 09/12/2025 01:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2025 04:16:02 PM

